Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

When you buy through links on our articles, Future and its syndication partners may earn a commission.

‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Once opened, compounded semaglutide typically lasts 28 days in the fridge. Compounded semaglutide, which contains the same active ...

Klarity connects you with healthcare providers to create a personalized plan and offers insights into 10 GLP-1 medications ... is a GLP-1 agonist containing semaglutide, the same active ...